Leukoencephalopathy with calcifications and cysts: a purely neurological disorder distinct from coats plus

John H Livingston1, Josephine Mayer2, Emma Jenkinson2

  • 1Department of Paediatric Neurology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.

Neuropediatrics
|January 11, 2014
PubMed

Insights

Leukoencephalopathy with calcifications and cysts (LCC) is a distinct neurological disorder, separate from Coats plus disease, characterized by specific brain abnormalities. Its genetic cause remains unknown.

Area of Science:

  • Neuroscience
  • Genetics
  • Radiology

Background:

  • Coats plus (CP) disease is linked to mutations in the CTC1 gene.
  • Leukoencephalopathy with calcifications and cysts (LCC) presents with similar radiological features to CP.
  • Distinguishing LCC from CP is crucial for accurate diagnosis and genetic counseling.

Purpose of the Study:

  • To describe the clinical and radiological features of LCC.
  • To differentiate LCC from other genetic leukoencephalopathies.
  • To highlight the distinct genetic basis of LCC.

Main Methods:

  • Retrospective analysis of 15 patients diagnosed with LCC.
  • Detailed description of clinical presentations and neuroimaging findings.
  • Genetic analysis to exclude CTC1 mutations.

Main Results:

  • LCC patients presented with seizures, motor abnormalities, and developmental delay.
  • Neuroimaging revealed diffuse leukoencephalopathy, calcifications in deep brain structures, and cysts.
  • All patients lacked mutations in the CTC1 gene, distinguishing LCC from CP.

Conclusions:

  • LCC is a distinct neurological disorder that shares neuroradiological findings with CP.
  • LCC is genetically distinct from CP due to the absence of CTC1 mutations.
  • The underlying molecular cause of LCC requires further investigation.
Abstract

Related Concept Videos

Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
19
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
22
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
15
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
30
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20